Jones Hill Capital LP

NEW YORK, NY · CIK 2102314 · 13F filing filed 2026-08-13

SEC-registered investment adviser since 2026 · limited partnership

Assets managed$642.4m
Staff8 · 4 in investment roles
Main clients (by assets)Private funds 100%
Private funds1 (1 hedge) · $230.3m gross assets
Websitejoneshillcapital.com
Form ADV · 2026-05-06SEC adviser record

Legal entityJones Hill Capital LP (US)

Kindhedge funds
Others nearbyNew York, NY

As an employer

Offices in1 country
Private fundshedge 1

$470.4m reported value +0.8% vs Q1 2026

29positions

68.8%in top 10

15 new 5 added 9 reduced 12 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#	Security	Ticker	Shares	Value	% of portfolio	Change	Shares change
1	BIOMARIN PHARMACEUTICAL INC COM BMRN	BMRN	1,431,590	$81.9m17.42%	17.42%	Added +163.2k	+163,200 12.9%
2	GILEAD SCIENCES INC COM GILD	GILD	343,043	$43.3m9.21%	9.21%	New
3	ARCUTIS BIOTHERAPEUTICS INC COM ARQT	ARQT	1,089,701	$28.6m6.07%	6.07%	New
4	MADRIGAL PHARMACEUTICALS INC COM MDGL	MDGL	52,545	$28.2m6.00%	6.00%	New
5	BICARA THERAPEUTICS INC COM BCAX	BCAX	892,621	$26.5m5.63%	5.63%	Reduced -367.5k	-367,515 -29.2%
6	RELMADA THERAPEUTICS INC COM RLMD	RLMD	3,655,075	$25.3m5.38%	5.38%	Added +3.3m	+3,312,323 966.4%
7	TREVI THERAPEUTICS INC COM TRVI	TRVI	1,339,212	$25.0m5.31%	5.31%	Added +969.0k	+969,037 261.8%
8	PHARVARIS N V COM PHVS	PHVS	677,879	$23.4m4.98%	4.98%	Added +510.9k	+510,865 305.9%
9	XENON PHARMACEUTICALS INC COM XENE	XENE	367,900	$22.2m4.72%	4.72%	New
10	ANI PHARMACEUTICALS INC COM ANIP	ANIP	233,808	$19.4m4.11%	4.11%	Reduced -84.8k	-84,783 -26.6%
11	IMMUNOCORE HLDGS PLC ADS IMCR	IMCR	512,856	$16.3m3.46%	3.46%	New
12	AMYLYX PHARMACEUTICALS INC COM AMLX	AMLX	894,058	$16.1m3.41%	3.41%	Reduced -704.7k	-704,736 -44.1%
13	INSMED INC COM PAR $.01 INSM	INSM	122,375	$13.0m2.77%	2.77%	New
14	NUVALENT INC COM COM		98,442	$12.2m2.58%	2.58%	Reduced -202.4k	-202,388 -67.3%
15	CAPRICOR THERAPEUTICS INC COM NEW CAPR	CAPR	420,751	$10.1m2.15%	2.15%	Reduced -488.5k	-488,456 -53.7%
16	ACLARIS THERAPEUTICS INC COM ACRS	ACRS	1,759,492	$9.3m1.98%	1.98%	New
17	IMMUNIC INC COM NEW IMUX	IMUX	539,814	$8.3m1.76%	1.76%	New
18	ORIC PHARMACEUTICALS INC COM ORIC	ORIC	747,313	$8.1m1.72%	1.72%	New
19	TONIX PHARMACEUTICALS HLDG C COM NEW TNXP	TNXP	625,428	$8.0m1.70%	1.70%	Added +173.3k	+173,312 38.3%
20	SYNDAX PHARMACEUTICALS INC COM SNDX	SNDX	340,000	$7.4m1.58%	1.58%	New
21	OLEMA PHARMACEUTICALS INC COM OLMA	OLMA	574,166	$7.2m1.53%	1.53%	New
22	VIR BIOTECHNOLOGY INC COM VIR	VIR	659,213	$6.7m1.43%	1.43%	Reduced -539.0k	-539,000 -45.0%
23	CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP	CRBP	653,572	$6.1m1.30%	1.30%	New
24	DIANTHUS THERAPEUTICS INC COM DNTH	DNTH	57,100	$5.6m1.18%	1.18%	New
25	VERTEX PHARMACEUTICALS INC COM VRTX	VRTX	11,123	$5.5m1.17%	1.17%	Reduced -97.5k	-97,480 -89.8%
26	ENLIVEN THERAPEUTICS INC COM ELVN	ELVN	49,850	$2.5m0.54%	0.54%	Reduced -543.2k	-543,190 -91.6%
27	STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR	GPCR	40,567	$2.2m0.46%	0.46%	Reduced -60.0k	-60,026 -59.7%
28	PHATHOM PHARMACEUTICALS INC COM PHAT	PHAT	161,486	$1.8m0.37%	0.37%	New
29	ACHIEVE LIFE SCIENCES INC COM ACHV	ACHV	26,760	$174.7k0.04%	0.04%	New

Sold out since Q1 2026

Security	Ticker	Shares held before	Value then
VAXCYTE INC PCVX	PCVX	644,831	$37.5m644.8k shares
TERNS PHARMACEUTICALS INC		521,237	$27.5m521.2k shares
ULTRAGENYX PHARMACEUTICAL IN RARE	RARE	1,165,557	$24.4m1.2m shares
ARGENX SE ARGX	ARGX	25,995	$19.0m26.0k shares
FULCRUM THERAPEUTICS INC FULC	FULC	1,771,926	$13.6m1.8m shares
NUVATION BIO INC NUVB	NUVB	2,383,031	$10.2m2.4m shares
ORUKA THERAPEUTICS INC ORKA	ORKA	140,843	$6.9m140.8k shares
CONTINEUM THERAPEUTICS INC CTNM	CTNM	513,053	$6.7m513.1k shares
VERADERMICS INC MANE	MANE	100,843	$6.4m100.8k shares
ENTRADA THERAPEUTICS INC TRDA	TRDA	374,010	$4.7m374.0k shares
SILENCE THERAPEUTICS PLC SLN	SLN	301,604	$1.6m301.6k shares
ARRIVENT BIOPHARMA INC AVBP	AVBP	45,809	$1.1m45.8k shares